REED VICKIE S 4
4 · Mirati Therapeutics, Inc. · Filed Jan 8, 2021
Insider Transaction Report
Form 4
REED VICKIE S
SVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2021-01-06$210.28/sh−527$110,818→ 7,712 total - Sale
Common Stock
2021-01-06$215.70/sh−11$2,373→ 8,239 total - Sale
Common Stock
2021-01-07$216.33/sh−241$52,135→ 7,471 total
Footnotes (3)
- [F1]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.
- [F2]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020.
- [F3]This transaction was executed in multiple trades at prices ranging from $215.657 to $216.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.